Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists

Finckh, Axel; Möller, Burkhard; Dudler, Jean; Walker, Ulrich A; Kyburz, Diego; Gabay, Cem; physicians of the Swiss Clinical Quality Management for Rheumato, ; physicians of SCQM-RA, (2012). Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Annals of the rheumatic diseases, 71(10), pp. 1680-5. London: BMJ Publishing Group 10.1136/annrheumdis-2011-201016

Full text not available from this repository. (Request a copy)

Observational studies have suggested that patients with rheumatoid arthritis (RA) who experience inadequate response to anti-tumour necrosis factor (anti-TNF) agents respond more favourably to rituximab (RTX) than to an alternative anti-TNF agent. However, the relative effectiveness of these agents on long-term outcomes, particularly in radiographic damage, remains unclear.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Möller, Burkhard

ISSN:

0003-4967

Publisher:

BMJ Publishing Group

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:40

Last Modified:

05 Dec 2022 14:12

Publisher DOI:

10.1136/annrheumdis-2011-201016

PubMed ID:

22419773

Web of Science ID:

000308747900015

URI:

https://boris.unibe.ch/id/eprint/16255 (FactScience: 223856)

Actions (login required)

Edit item Edit item
Provide Feedback